• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哺乳动物微粒体酶促进抗克氏锥虫药物活化为基因毒性代谢物。

Activation of anti-Trypanosoma cruzi drugs to genotoxic metabolites promoted by mammalian microsomal enzymes.

作者信息

Ferreira R C, Schwarz U, Ferreira L C

机构信息

Departamento de Biofísica e Radiobiologia, Cidade Universitária, Recife.

出版信息

Mutat Res. 1988 Apr;204(4):577-83. doi: 10.1016/0165-1218(88)90060-2.

DOI:10.1016/0165-1218(88)90060-2
PMID:3280991
Abstract

Salmonella typhimurium TA100 and its nitroreductase-deficient derivative, TA100 NR, were used to reevaluate the mutagenic activities of benznidazole and nifurtimox. Mutagenicity and toxicity of nifurtimox were abolished in the TA100 NR tester strain under aerobic or anaerobic conditions and addition of rat liver extracts did not alter the results. However, benznidazole showed a significant mutagenicity and toxicity to the nitroreductase-deficient strain TA100 NR under hypoxic conditions. Addition of rat liver extracts enhanced the observed mutagenicity and toxicity of benznidazole even more. In the presence of O2 the genotoxic activities of benznidazole to the TA100 NR tester strain were eliminated. These results lead us to conclude that bacterial enzymes were responsible for the previously observed genotoxic effects of nifurtimox and benznidazole on S. typhimurium TA100. Moreover, under anaerobic conditions, only benznidazole could be metabolized by mammalian nitroreductases into a mutagenic derivative.

摘要

鼠伤寒沙门氏菌TA100及其硝基还原酶缺陷型衍生物TA100 NR被用于重新评估苯硝唑和硝呋替莫的致突变活性。在需氧或厌氧条件下,硝呋替莫在TA100 NR测试菌株中的致突变性和毒性均被消除,添加大鼠肝脏提取物也未改变结果。然而,在缺氧条件下,苯硝唑对硝基还原酶缺陷型菌株TA100 NR表现出显著的致突变性和毒性。添加大鼠肝脏提取物甚至进一步增强了所观察到的苯硝唑的致突变性和毒性。在有氧存在的情况下,苯硝唑对TA100 NR测试菌株的遗传毒性活性被消除。这些结果使我们得出结论,细菌酶是之前观察到的硝呋替莫和苯硝唑对鼠伤寒沙门氏菌TA100的遗传毒性作用的原因。此外,在厌氧条件下,只有苯硝唑可被哺乳动物硝基还原酶代谢为一种致突变衍生物。

相似文献

1
Activation of anti-Trypanosoma cruzi drugs to genotoxic metabolites promoted by mammalian microsomal enzymes.哺乳动物微粒体酶促进抗克氏锥虫药物活化为基因毒性代谢物。
Mutat Res. 1988 Apr;204(4):577-83. doi: 10.1016/0165-1218(88)90060-2.
2
Mutagenicity of nifurtimox and benznidazole in the Salmonella/microsome assay.
Braz J Med Biol Res. 1986;19(1):19-25.
3
Mutagenicity of 2 anti-chagasic drugs and their metabolic deactivation.
Mutat Res. 1983 May-Jun;117(3-4):237-42. doi: 10.1016/0165-1218(83)90124-6.
4
Evaluation of genotoxic activity in the blood and urine of guinea pigs treated with nifurtimox and benznidazole.对用硝呋替莫和苯硝唑治疗的豚鼠血液和尿液中的遗传毒性活性进行评估。
Braz J Med Biol Res. 1988;21(5):1069-77.
5
Ultrastructural alterations in ovaries from nifurtimox or benznidazole-treated rats: their relation to ovarian nitroreductive biotransformation of both drugs.硝呋替莫或苄硝唑治疗大鼠卵巢的超微结构改变:其与两种药物卵巢硝基还原生物转化的关系。
Exp Mol Pathol. 1989 Jun;50(3):385-97. doi: 10.1016/0014-4800(89)90047-6.
6
Liver microsomal benznidazole and nifurtimox nitroreductase activity in male rats of different age.不同年龄雄性大鼠肝脏微粒体中苯并硝唑和硝呋替莫的硝基还原酶活性
Arch Int Pharmacodyn Ther. 1987 Sep;289(1):11-7.
7
Species and sex differences in the liver microsomal nitroreductive biotransformation of nifurtimox and benznidazole.硝呋替莫和苯硝唑在肝脏微粒体中的硝基还原生物转化的物种和性别差异。
Arch Int Pharmacodyn Ther. 1987 Jun;287(2):181-7.
8
Role of classical nitroreductase and O-acetyltransferase on the mutagenicity of nifurtimox and eight derivatives in Salmonella typhimurium.经典硝基还原酶和O-乙酰转移酶对硝呋替莫及其八种衍生物在鼠伤寒沙门氏菌中致突变性的作用。
Environ Mol Mutagen. 1995;26(1):86-93. doi: 10.1002/em.2850260113.
9
Mutagenicity studies on fenitrothion in bacteria and mammalian cells.杀螟硫磷在细菌和哺乳动物细胞中的致突变性研究。
Mutat Res. 1989 Jan;222(1):53-61. doi: 10.1016/0165-1218(89)90035-9.
10
Genetic differences between the standard Ames tester strains TA100 and TA98.标准艾姆斯试验菌株TA100和TA98之间的基因差异。
Mutagenesis. 1993 Nov;8(6):527-32. doi: 10.1093/mutage/8.6.527.

引用本文的文献

1
Functionalized Nitroimidazole Scaffold Construction and Their Pharmaceutical Applications: A 1950-2021 Comprehensive Overview.功能化硝基咪唑支架的构建及其药物应用:1950 - 2021年综述
Pharmaceuticals (Basel). 2022 Apr 30;15(5):561. doi: 10.3390/ph15050561.
2
Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole.三种市售硝基杂环药物的遗传毒性再评估:硝呋替莫、苯硝唑和甲硝唑。
J Parasitol Res. 2009;2009:463575. doi: 10.1155/2009/463575. Epub 2009 Oct 21.